COVID-19 Vaccine Intent Among Health Care Professionals of Queen Elizabeth Hospital, Barbados.
Barbados
COVID-19
healthcare professionals
vaccine hesitancy
vaccine intake
vaccine literacy
Journal
Journal of multidisciplinary healthcare
ISSN: 1178-2390
Titre abrégé: J Multidiscip Healthc
Pays: New Zealand
ID NLM: 101512691
Informations de publication
Date de publication:
2021
2021
Historique:
received:
31
08
2021
accepted:
17
11
2021
entrez:
8
12
2021
pubmed:
9
12
2021
medline:
9
12
2021
Statut:
epublish
Résumé
Due to increased exposure risk and the potential impact of COVID-19 infection, health care professionals (HCP) are a target group for COVID-19 vaccination. This study aimed to examine the acceptability of COVID-19 vaccines among HCP at the Queen Elizabeth Hospital, Barbados. A cross-sectional survey of HCP was conducted between February 14 and 27, 2021 using an online questionnaire. The questionnaire included demographic information, knowledge of novel coronavirus, intention to accept the COVID-19 vaccination, vaccine literacy (VL), and perceptions and attitudes regarding COVID-19 vaccines. Mean VL scores were calculated. The relationship between socio-demographic variables and vaccine intent was assessed using a multivariable logistic regression model. Of 343 HCPs, 55.1% indicated they would accept the COVID-19 vaccine if it were available; 44.9% expressed hesitancy towards the COVID-19 vaccine. We assessed the impact of socio-demographic factors and previous vaccine behavior on vaccine intent; after adjustment of the multivariable logistic regression model, non-Barbadian nationality and previous flu vaccine uptake were statistically significant predictors of reported intent to take the COVID-19 vaccine. Persons who indicated that they would take the vaccine had a higher mean vaccine literacy score [3.46 95% CI (3.40, 3.52)] than those who were not ready to take the vaccine immediately [3.23 95% CI (3.15, 3.30)]. VL scores were higher among the 29.5% of HCPs who believed vaccines should be mandatory. This study highlighted vaccine hesitancy among HCPs in the sole public tertiary hospital of Barbados. As HCP perceptions may help or hinder the campaign to promote vaccine uptake in Barbados, vaccine promotion programs targeting HCPs are needed to ensure the success of the country's COVID-19 vaccination drive.
Identifiants
pubmed: 34876817
doi: 10.2147/JMDH.S336952
pii: 336952
pmc: PMC8643144
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3309-3319Informations de copyright
© 2021 Krishnamurthy et al.
Déclaration de conflit d'intérêts
Dr Md Anwarul Azim Majumder is the Editor-in-Chief of the journal Advances in Medical Education and Practice and reports no other potential conflicts of interest for this work. The other authors report no conflicts of interest in this work.
Références
Cureus. 2021 Sep 15;13(9):e17990
pubmed: 34667668
Vaccines (Basel). 2019 Dec 24;8(1):
pubmed: 31878271
Vaccine. 2021 Apr 8;39(15):2024-2034
pubmed: 33722411
PLoS Med. 2021 Nov 5;18(11):e1003823
pubmed: 34739480
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
J Korean Med Sci. 2021 Mar 15;36(10):e78
pubmed: 33724740
Vaccines (Basel). 2021 Apr 23;9(5):
pubmed: 33922812
EClinicalMedicine. 2021 Oct;40:101113
pubmed: 34490416
Int J Nurs Stud. 2013 Oct;50(10):1399-406
pubmed: 23395482
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Ann Intern Med. 2021 Jun;174(6):882-885
pubmed: 33556267
Vaccine. 2020 Oct 21;38(45):7049-7056
pubmed: 32980199
Lancet. 2020 Mar 21;395(10228):942-943
pubmed: 32171075
Clin Infect Dis. 2021 Nov 16;73(10):1776-1783
pubmed: 33491049
Expert Rev Vaccines. 2020 Nov;19(11):991-993
pubmed: 32940574
Vaccines (Basel). 2021 Feb 03;9(2):
pubmed: 33546165
Expert Rev Anti Infect Ther. 2020 Dec;18(12):1201-1211
pubmed: 32749914
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Expert Rev Clin Pharmacol. 2021 May;14(5):601-621
pubmed: 33705239
BMC Health Serv Res. 2017 Nov 15;17(1):732
pubmed: 29141619
Hum Vaccin Immunother. 2021 May 4;17(5):1304-1312
pubmed: 33118868
Vaccines (Basel). 2021 Jul 12;9(7):
pubmed: 34358193
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Vaccines (Basel). 2020 Aug 27;8(3):
pubmed: 32867224
Vaccine. 2020 Oct 21;38(45):7002-7006
pubmed: 32988688
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478623
Vaccine. 2012 Jul 6;30(32):4813-9
pubmed: 22643215
JAMA. 2016 Mar 15;315(11):1149-58
pubmed: 26978210
Am J Infect Control. 2021 Sep;49(9):1152-1157
pubmed: 33930516
Can Commun Dis Rep. 2020 Nov 05;46(1112):432-435
pubmed: 33447164
J Public Health (Oxf). 2021 Jun 7;43(2):e338-e339
pubmed: 33675364
Immunity. 2020 May 19;52(5):737-741
pubmed: 32433946
BMJ. 2021 May 20;373:n1138
pubmed: 34016653
MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):853-858
pubmed: 32644979
Lancet Infect Dis. 2013 Jul;13(7):606-13
pubmed: 23676442
Data Brief. 2020 Dec;33:106446
pubmed: 33106773
J Hosp Infect. 2021 Feb;108:168-173
pubmed: 33259883
Risk Manag Healthc Policy. 2021 Aug 14;14:3395-3401
pubmed: 34421317
PLoS One. 2021 Nov 29;16(11):e0244415
pubmed: 34843462
Acad Emerg Med. 2021 Apr;28(4):455-458
pubmed: 33608937
JAMA Netw Open. 2021 Mar 1;4(3):e215344
pubmed: 33755164
Hum Vaccin Immunother. 2021 Mar 4;17(3):664-672
pubmed: 33124954
Expert Rev Vaccines. 2021 Sep;20(9):1167-1175
pubmed: 34224292